<DOC>
	<DOCNO>NCT00931775</DOCNO>
	<brief_summary>The purpose study examine whether speed clinical antidepressant action citalopram accelerate administer double dos pindolol ( 15 mg/day , tid ) presumably lead increase 5-HT1A autoreceptor occupancy .</brief_summary>
	<brief_title>Citalopram Versus Citalopram Plus Pindolol Major Depressive Disorder</brief_title>
	<detailed_description>Design , Settings , Participants . A randomised , double-blind , placebo-controlled trial MDD patient allocate two treatment arm : citalopram + pindolol versus citalopram + placebo . Participants : outpatient depressive episode ( DSM-IV criterion ) select general hospital .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Pindolol</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Patients depressive episode HDRS score &gt; 18 Written inform consent suicidal risk &gt; 3 severe organic illness psychotropic drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Major depressive disorder , citalopram , pindolol , HDRS</keyword>
</DOC>